-
1Academic Journal
Συγγραφείς: Антон Деникин
Πηγή: Челябинский гуманитарий, Iss 2 (67), Pp 16–22-16–22 (2024)
Θεματικοί όροι: биогенетика, мутанты, клоны, биотвари, микробиологические коммуникации, межклеточные коммуникации, коммуникации с телами, межвидовые коммуникации, Philology. Linguistics, P1-1091, Education (General), L7-991
Περιγραφή αρχείου: electronic resource
Σύνδεσμος πρόσβασης: https://doaj.org/article/b9be289214be4d8cac0847ecb6e59494
-
2Academic Journal
Συγγραφείς: M. V. Lakhtin, V. M. Lakhtin, V. A. Aleshkin, M. S. Afanasiev, S. S. Afanasiev, М. В. Лахтин, В. М. Лахтин, В. А. Алёшкин, М. С. Афанасьев, С. С. Афанасьев
Πηγή: Acta Biomedica Scientifica; Том 3, № 4 (2018); 69-77 ; 2587-9596 ; 2541-9420
Θεματικοί όροι: антираковые вакцины, receptor lectins, glycoconjugates, adjuvants, cell targeting, dendritic cells, macrophages, M-cells, NK-cells, cell subpopulations, innate immunity, anticancer therapy, anticancer v accines, лектины, гликоконъюгаты, адъюванты, дендритные клетки, макрофаги, М-клетки, NK-клетки, врождённый иммунитет, субпопуляции клеток, межклеточные коммуникации, антираковая терапия
Περιγραφή αρχείου: application/pdf
Relation: https://www.actabiomedica.ru/jour/article/view/652/645; Лахтин М.В., Лахтин В.М., Афанасьев С.С., Алешкин В.А. Лектины: перспективы в иммунологии, микробиологии и биотехнологии // Уральский научный вестник. – 2017. – Т. 3, № 12. – С. 25–47. Lakhtin MV, Lakhtin VM, Afanasiev SS, Aleshkin VA. (2017). Lectins: prospects in immunology, microbiology and biotechnology [Lektiny: perspektivy v immunologii, mikrobiologii i biotekhnologii]. Ural’skiy nauchnyy vestnik, 3 (12), 25-47.; Лахтин М.В., Лахтин В.М., Афанасьев С.С., Байракова А.Л., Алешкин В.А., Афанасьев М.С. Кандидные маркеры болезней урогенитальных биотопов: реактивность к лектинам пробиотиков // Acta Biomedica Scientifica. – 2018. – Т. 3, № 1. – С. 49–53. DOI:10.29413/ABS.2018-3.1.7 Lakhtin MV, Lakhtin VM, Afanasiev SS, Bayrakova AL, Aleshkin VA, Afanasiev MS. (2018). Candida markers of urogenital biotopes diseases: reactivity to lectins of probiotics [Kandidnye markery bolezney urogenital’nykh biotopov: reaktivnost’ k lektinam probiotikov]. Acta Biomedica Scientifica, 3 (1), 49-53. DOI:10.29413/ABS.2018-3.1.7; Alves AM, Diel LF, Lamers ML. (2017). Macrophages and prognosis of oral squamous cell carcinoma: a systematic review. J Oral Pathol Med, 47 (5), 460-467. DOI:10.1111/jop.12643; Andersen MN, Andersen NF, Rødgaard-Hansen S, Hokland M, Abildgaard N, Møller HJ. (2015). The novel biomarker of alternative macrophage activation, soluble mannose receptor (sMR/sCD206): implications in multiple myeloma. Leuk Res, 39 (9), 971-975. DOI:10.1016/j.leukres.2015.06.003; Boeck CL, Amberger DC, Doraneh-Gard F, Sutanto W, Guenther T, Schmohl J, Schuster F, Salih H, Babor F, Borkhardt A, Schmetzer H. (2017). Significance of frequencies, compositions, and/or antileukemic activity of (DC-stimulated) invariant NKT, NK and CIK cells on the outcome of patients with AML, ALL and CLL. J Immunother, 40 (6), 224-248. DOI:10.1097/CJI.0000000000000171; Caley MP, King H, Shah N, Wang K, Rodriguez-Teja M, Gronau JH, Waxman J, Sturge J. (2016). Tumor-associated Endo180 requires stromal-derived LOX to promote metastatic prostate cancer cell migration on human ECM surfaces. Clin Exp Metastasis, 33 (2), 151-165. DOI:10.1007/s10585-015-9765-7; Cordeau M, Belounis A, Lelaidier M, Cordeiro P, Sartelet H, Herblot S, Duval M. (2016). Efficient killing of high risk neuroblastoma using natural killer cells activated by plasmacytoid dendritic cells. PLoS One, 11 (10), e0164401. DOI: 0.1371/journal.pone.0164401; Chen C, Li K, Jiang H, Song F, Gao H, Pan X, Shi B, Bi Y, Wang H, Wang H, Li Z. (2017). Development of T cells carrying two complementary chimeric antigen receptors against Glypican-3 and asialoglycoprotein receptor 1 for the treatment of hepatocellular carcinoma. Cancer Immunol Immunother, 66 (4), 475-489. DOI:10.1007/s00262-016-1949-8; Chowdhury SR, Ray U, Chatterjee BP, Roy SS. (2017). Targeted apoptosis in ovarian cancer cells through mitochondrial dysfunction in response to Sambucus nigra agglutinin. Cell Death Dis, 8 (5), e2762. DOI:10.1038/cddis.2017.77; Costa F, Vescovini R, Bolzoni M, Marchica V, Storti P, Toscani D , Accardi F , Notarfranchi L, Dalla Palma B, Manferdini C, Manni S, Todaro G, Lisignoli G, Piazza F, Aversa F, Giuliani N. (2017). Lenalidomide increases human dendritic cell maturation in multiple myeloma patients targeting monocyte differentiation and modulating mesenchymal stromal cell inhibitory properties. Oncotarget, 8 (32), 53053-53067. DOI:10.18632/oncotarget.18085; Daley D, Mani VR, Mohan N, Akkad N, Ochi A, Heindel DW, Lee KB, Zambirinis CP, Pandian GSB, Savadkar S, Torres-Hernandez A, Nayak S, Wang D, Hundeyin M, Diskin B, Aykut B, Werba G, Barilla RM, Rodriguez R, Chang S, Gardner L, Mahal LK, Ueberheide B, Miller G. (2017). Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance. Nat Med, 23 (5), 556-567. DOI:10.1038/nm.4314; Di Caro G, Cortese N, Castino GF, Grizzi F, Gavazzi F, Ridolfi C, Capretti G, Mineri R, Todoric J, Zerbi A, Allavena P, Mantovani A, Marchesi F. (2016). Dual prognostic significance of tumour-associated macrophages in human pancreatic adenocarcinoma treated or untreated with chemotherapy. Gut, 65 (10), 1710-1720. DOI:10.1136/gutjnl-2015-309193; Ding D, Song Y, Yao Y, Zhang S. (2017). Preoperative serum macrophage activated biomarkers soluble mannose receptor (sMR) and soluble haemoglobin scavenger receptor (sCD163), as novel markers for the diagnosis and prognosis of gastric cancer. Oncol Lett, 14 (3), 2982-2990. DOI:10.3892/ol.2017.6547; van Dinther D, Stolk DA, van de Ven R, van Kooyk Y, de Gruijl TD, den Haan JMM. (2017). Targeting C-type lectin receptors: a high-carbohydrate diet for dendritic cells to improve cancer vaccines. J Leukoc Biol, 102 (4), 1017-1034. DOI:10.1189/jlb.5MR0217-059RR; Faddaoui A, Bachvarova M, Plante M, Gregoire J, Renaud MC, Sebastianelli A. Gobeil S, Morin C, Macdonald E, Vanderhyden B, Bachvarov D. (2016). The mannose receptor LY75 (DEC205/CD205) modulates cellular phenotype and metastatic potential of ovarian cancer cells. Oncotarget, 7 (12), 14125-14142. DOI:10.18632/oncotarget.7288; Feng D, Shaikh AS, Wang F. (2016). Recent advance in tumor-associated carbohydrate antigens (TACAs)- based antitumor vaccines. ACS Chem Biol, 11 (4), 850-863. DOI:10.1021/acschembio.6b00084; Goswami KK, Ghosh T, Ghosh S, Sarkar M, Bose A, Baral R. (2017). Tumor promoting role of anti-tumor macrophages in tumor microenvironment. Cell Immunol, 316, 1-10. DOI:10.1016/j.cellimm.2017.04.005; Haas T, Heidegger S, Wintges A, Bscheider M, Bek S, Fischer JC, Eisenkolb G, Schmickl M, Spoerl S, Peschel C, Poeck H, Ruland J. (2017). Card9 controls dectin-1-induced t-cell cytotoxicity and tumor growth in mice. Eur J Immunol, 47 (5), 872-879. DOI:10.1002/eji.201646775; Hollander N, Haimovich J. (2017). Altered N-linked glycosylation in follicular lymphoma and chronic lymphocytic leukemia: involvement in pathogenesis and potential therapeutic targeting. Front Immunol, 2017 Aug 2; 8: 912. DOI:10.3389/fimmu.2017.00912; Kang HG, Kim DH, Kim SJ, Cho Y, Jung J, Jang W, Chun KH. (2016). Galectin-3 supports stemness in ovarian cancer stem cells by activation of the Notch1 intracellular domain. Oncotarget, 7 (42), 68229-68241. DOI:10.18632/oncotarget.11920; Kawashima K, Maeda K, Saigo C, Kito Y, Yoshida K, Takeuchi T. (2017). Adiponectin and Intelectin-1: important adipokine players in obesity-related colorectal carcinogenesis. Int J Mol Sci, 2017 Apr 19; 18 (4), pii: E866. DOI:10.3390/ijms18040866; Klauber TCB, Laursen JM, Zucker D, Brix S, Jensen SS, Andresen TL. (2017). Delivery of TLR7 agonist to monocytes and dendritic cells by DCIR targeted liposomes induces robust production of anti-cancer cytokines. Acta Biomater, 53, 367-377. DOI:10.1016/j.actbio.2017.01.072; Komohara Y, Ohnishi K, Takeya M. (2017). Possible functions of CD169-positive sinus macrophages in lymph nodes in anti-tumor immune responses. Cancer Sci, 108 (3), 290-295. DOI:10.1111/cas.13137; Kovaleva OV, Samoilova DV, Shitova MS, Gratchev A. (2016). Tumor associated macrophages in kidney cancer. Anal Cell Pathol (Amst), 2016, 9307549.; Laborda E, Mazagova M, Shao S, Wang X, Quirino H, Woods AK, Hampton EN, Rodgers DT, Kim CH, Schultz PG, Young TS. (2017). Development of a chimeric antigen receptor targeting C-type lectin-like molecule-1 for human acute myeloid leukemia. Int J Mol Sci, 18 (11), 2259. DOI:10.3390/ijms18112259; Li X. (2016). TIPE2 regulates tumor-associated macrophages in skin squamous cell carcinoma. Tumour Biol, 37 (4), 5585-5590. DOI:10.1007/s13277-015-4388-9; Mattila JP, Mirandola L, Chiriva-Internati M. (2018). Development of a M cell-targeted microparticulate platform, BSK02™, for oral immunization against the ovarian cancer antigen, sperm protein 17. J Biomed Mater Res B Appl Biomater, 4. DOI:10.1002/jbm.b.34092; McKee SJ, Doff BL, Soon MS, Mattarollo SR. (2017). Therapeutic efficacy of 4-1BB costimulation is abrogated by PD-1 blockade in a model of spontaneous B-cell lymphoma. Cancer Immunol Res, 5 (3), 191-197. DOI:10.1158/2326-6066.CIR-16-0249; Mehta RS, Rezvani K. (2018). Chimeric antigen receptor expressing natural killer cells for the immunotherapy of cancer. Front Immunol, 15 (9), 283. DOI:10.3389/fimmu.2018.00283; Montraveta A, Lee-Vergés E, Roldán J, Jiménez L, Cabezas S, Clot G, Pinyol M, Xargay- Torrent S, Rosich L, Arimany-Nardí C, Aymerich M, Villamor N, López-Guillermo A, Pérez- Galán P, Roué G, Pastor-Anglada M, Campo E, López-Guerra M, Colomer D. (2016). CD69 expression potentially predicts response to bendamustine and its modulation by ibrutinib or idelalisib enhances cytotoxic effect in chronic lymphocytic leukemia. Oncotarget, 7 (5), 5507-5520. DOI:10.18632/oncotarget.6685; Monzavi-Karbassi B, Jousheghany F, Kieber-Emmons T. (2016). Tumor-associated glycans and tregs in immunogenicity of an autologous cell-based vaccine. Immunol Invest, 19, 1-13.; Nan J, Xing YF, Hu B, Tang JX, Dong HM, He YM, Ruan DY, Ye QJ, Cai JR, Ma XK, Chen J, Cai XR, Lin ZX, Wu XY, Li X. (2017). Endoplasmic reticulum stress induced LOX-1+ CD15+ polymorphonuclear myeloid-derived suppressor cells in hepatocellular carcinoma. Immunology, 154 (1), 144-155. DOI:10.1111/imm.12876; Natoni A, Smith TAG, Keane N, McEllistrim C, Connolly C, Jha A, Andrulis M, Ellert E, Raab MS, Glavey SV, Kirkham-McCarthy L, Kumar SK, Locatelli-Hoops SC, Oliva I, Fogler WE, Magnani JL, O’Dwyer ME. (2017). E-selectin ligands recognized by HECA452 induce drug resistance in myeloma, which is overcome by the E-selectin antagonist, GMI-1271. Leukemia, 31 (12), 2642-2651. DOI:10.1038/leu.2017.123; Rodriguez MC, Yongye AB, Cudic M, Martinez Mayorga K, Liu E, Mueller BM, Ainsley J, Karabencheva-Christova T, Christov CZ, Cudic M, Cudic P. (2017). Targeting cancer-specific glycans by cyclic peptide lectinomimics. Amino Acids, 49 (11), 1867-1883. DOI:10.1007/s00726-017-2485-3; Roperto S, Russo V, Esposito I, Ceccarelli DM, Paciello O, Avallone L, Capparelli R, Roperto F. (2015). Mincle, an innate immune receptor, is expressed in urothelial cancer cells of papillomavirus-associated urothelial tumors of cattle. PLoS One, 10 (10), 0141624. DOI:10.1371/journal.pone.0141624; Sabado RL, Balan S, Bhardwaj N. (2017). Dendritic cell-based immunotherapy. Cell Res, 27 (1), 74-95. DOI:10.1038/cr.2016.157; Saluja SS, Hanlon DJ, Sharp FA, Hong E, Khalil D, Robinson E, Tigelaar R, Fahmy TM, Edelson RL. (2014). Targeting human dendritic cells via DEC-205 using PLGA nanoparticles leads to enhanced cross-presentation of a melanoma-associated antigen. Int J Nanomedicine, 9, 5231-5146. DOI:10.2147/IJN.S66639; Sluijter BJ, van den Hout MF, Koster BD, van Leeuwen PA, Schneiders FL, van de Ven R, Molenkamp BG, Vosslamber S, Verweij CL, van den Tol MP, van den Eertwegh AJ, Scheper RJ, de Gruijl TD. (2015). Arming the melanoma sentinel lymph node through local administration of CpG-B and GM-CSF: Recruitment and activation of BDCA3/CD141+ dendritic cells and enhanced cross-presentation. Cancer Immunol Res, 3 (5), 495-505. DOI:10.1158/2326-6066.CIR-14-0165; Song JX, Dian ZJ, Wen Y, Mei F, Li RW, Sa YL. (2016). Assessment of the number and phenotype of macrophages in the human BMB samples of CML. Biomed Res Int, 2016, 8086398. DOI:10.1155/2016/8086398; Strömvall K, Sundkvist K, Ljungberg B, Halin Bergström S, Bergh A. (2017). Reduced number of CD169+ macrophages in pre-metastatic regional lymph nodes is associated with subsequent metastatic disease in an animal model and with poor outcome in prostate cancer patients. Prostate, 77 (15), 1468-1477. DOI:10.1002/pros.23407; Sturge J. (2016). Endo180 at the cutting edge of bone cancer treatment and beyond. J Pathol, 238 (4), 485-488. DOI:10.1002/path.4673; Tawde SA, Chablani L, Akalkotkar A, D’Souza MJ. (2016). Evaluation of microparticulate ovarian cancer vaccine via transdermal route of delivery. J Control Release, 235, 147-154. DOI:10.1016/j.jconrel.2016.05.058; Thordardottir S, Schaap N, Louer E, Kester MG, Falkenburg JH, Jansen J, Radstake TR, Hobo W, Dolstra H. (2017). Hematopoietic stem cell-derived myeloid and plasmacytoid DC- based vaccines are highly potent inducers of tumor-reactive T cell and NK cell responses ex vivo. Oncoimmunology, 6 (3), 1285991. DOI:10.1080/2162402X.2017.1285991; Wang J, Chen S, Xiao W, Li W, Wang L, Yang S, , Xu L, Liao S, Liu W, Wang Y, Liu N, Zhang J, Xia X, Kang T, Chen G, Cai X, Yang H, Zhang X, Lu Y, Zhou P. (2018). CAR-T cells targeting CLL-1 as an approach to treat acute myeloid leukemia. J Hematol Oncol, 11 (1), 7. DOI:10.1186/s13045-017-0553-5; Wang L, Yin J, Wang X, Shao M, Duan F, Wu W, Peng P, Jin J, Tang Y, Ruan Y, Sun Y, Gu J. (2016). C-type lectin-like receptor 2 suppresses AKT signaling and invasive activities of gastric cancer cells by blocking expression of phosphoinositide 3-kinase subunits. Gastroenterology, 150 (5), 1183-1195.e16. DOI:10.1053/j.gastro.2016.01.034; Weng TY, Li CJ, Li CY, Hung YH, Yen MC, Chang YW, Chen YH, Chen YL, Hsu HP, Chang JY1, Lai MD. (2017). Skin delivery of Clec4a small hairpin RNA elicited an effective antitumor response by enhancing CD8+ immunity in vivo. Mol Ther Nucleic Acids, 9, 419-427. DOI:10.1016/j.omtn.2017.10.015; Yin W, Duluc D, Joo H, Oh S. (2016). dendritic cell targeting vaccine for HPV-associated cancer. Cancer Cell Microenviron, 3 (4), 1482. Epub 2017 Jan 15.; Zhang A, Qian Y, Ye Z, Chen H, Xie H, Zhou L, Shen Y, Zheng S. (2017). Cancer-associated fibroblasts promote M2 polarization of macrophages in pancreatic ductal adenocarcinoma. Cancer Med, 6 (2), 463-470. DOI:10.1002/cam4.993; https://www.actabiomedica.ru/jour/article/view/652
-
3Academic Journal
Πηγή: Вестник Волгоградского государственного медицинского университета.
Θεματικοί όροι: ЩЕЛЕВЫЕ КОНТАКТЫ,МЕЖКЛЕТОЧНЫЕ КОММУНИКАЦИИ,CELL-CELL COMMUNICATION,ЛЕЙКОЗ,LEUKEMIA,КЛЕТКИ JURKAT,JURKAT CELLS,GAP JUNCTIONS
Περιγραφή αρχείου: text/html
-
4Electronic Resource
Additional Titles: Перспективы применения экзосом в клинической практике
Перспективи застосування екзосом у клінічній практиціΣυγγραφείς: Muzychenko, P.F.; Bogomolets National Medical University, Kyiv, Ukraine, Chernyak, V.A.; Bogomolets National Medical University, Kyiv, Ukraine, Shevchenko, O.O.; Bogomolets National Medical University, Kyiv, Ukraine, Levon, M.M.; Bogomolets National Medical University, Kyiv, Ukraine
Πηγή: ТРАВМА; Том 20, № 5 (2019); 84-87; TRAUMA; 2307-1397; 1608-1706
Όροι ευρετηρίου: exosomes, intercellular communication, target cells, oncology, regeneration, skeletal system, cardiovascular diseases, экзосомы, межклеточные коммуникации, клетки-мишени, онкология, регенерация, костная система, сердечно-сосудистые заболевания, екзосоми, міжклітинні комунікації, клітини-мішені, онкологія, регенерація, кісткова система, серцево-судинні захворювання, info:eu-repo/semantics/article, info:eu-repo/semantics/publishedVersion
